Tumor Cell Invasion
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
LIM kinase 1 (LIMK1) is implicated in cellular mechanisms regulating tumour cell invasion and may be involved in ovarian carcinoma progression.
|
22906279 |
2012 |
Borderline Personality Disorder
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
PDLIM5 mRNA expression did not appear to be a reflection of the efficacy of olanzapine in reducing the manic symptoms of BPD.
|
23031404 |
2012 |
Bronchopulmonary Dysplasia
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
PDLIM5 mRNA expression did not appear to be a reflection of the efficacy of olanzapine in reducing the manic symptoms of BPD.
|
23031404 |
2012 |
Malignant neoplasm of breast
|
0.100 |
Biomarker
|
disease |
BEFREE |
LIM kinase inhibition reduces breast cancer growth and invasiveness but systemic inhibition does not reduce metastasis in mice.
|
23239465 |
2013 |
Breast Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
LIM kinase inhibition reduces breast cancer growth and invasiveness but systemic inhibition does not reduce metastasis in mice.
|
23239465 |
2013 |
Malignant Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
LIM and SH3 protein 1 (LASP1) is an actin-binding protein which is overexpressed in many types of cancers and plays important roles in cancer progression. however, the role of LASP1 in esophageal squamous cell carcinoma (ESCC) is still unknown.
|
23254782 |
2013 |
Tumor Progression
|
0.040 |
AlteredExpression
|
phenotype |
BEFREE |
LIM and SH3 protein 1 (LASP1) is an actin-binding protein which is overexpressed in many types of cancers and plays important roles in cancer progression. however, the role of LASP1 in esophageal squamous cell carcinoma (ESCC) is still unknown.
|
23254782 |
2013 |
Squamous cell carcinoma of esophagus
|
0.010 |
Biomarker
|
disease |
BEFREE |
LIM and SH3 protein 1 (LASP1) is an actin-binding protein which is overexpressed in many types of cancers and plays important roles in cancer progression. however, the role of LASP1 in esophageal squamous cell carcinoma (ESCC) is still unknown.
|
23254782 |
2013 |
Primary malignant neoplasm
|
0.080 |
Biomarker
|
group |
BEFREE |
LIM-domain-only proteins in cancer.
|
23303138 |
2013 |
Malignant neoplasm of breast
|
0.100 |
Biomarker
|
disease |
BEFREE |
LIM-only protein 4 (LMO4) is strongly linked to the progression of breast cancer.
|
23353824 |
2013 |
Breast Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
LIM-only protein 4 (LMO4) is strongly linked to the progression of breast cancer.
|
23353824 |
2013 |
Neoplasms
|
0.090 |
Biomarker
|
group |
BEFREE |
LIM kinase 2 (LIMK2) promotes tumour cell invasion and metastasis.
|
23585469 |
2014 |
Tumor Cell Invasion
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
LIM kinase 2 (LIMK2) promotes tumour cell invasion and metastasis.
|
23585469 |
2014 |
Neoplasm Metastasis
|
0.080 |
Biomarker
|
phenotype |
BEFREE |
LIM kinase 2 (LIMK2) promotes tumour cell invasion and metastasis.
|
23585469 |
2014 |
Neurofibromatosis 2
|
0.010 |
Biomarker
|
disease |
BEFREE |
LIM domain kinases as potential therapeutic targets for neurofibromatosis type 2.
|
23934191 |
2014 |
Malignant transformation
|
0.020 |
Biomarker
|
phenotype |
BEFREE |
LIM kinase 1 (LIMK1) is a member of a novel class of serine-threonine protein kinases, which plays an important role in malignant transformation.
|
24063279 |
2013 |
Malignant transformation
|
0.020 |
Biomarker
|
phenotype |
BEFREE |
LIM kinase 1 (LIMK1), an essential protein for malignant transformation, was found to be a target of miR-27b.
|
24390089 |
2014 |
Major depression, single episode
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
PDLIM5, S100A10 and TNF mRNA showed also an interesting pattern of expression with regards to MDE evolution.
|
24620999 |
2014 |
Neoplasm Metastasis
|
0.080 |
Biomarker
|
phenotype |
BEFREE |
LIM kinase 1 (Limk1) is associated with cell prolife-ration and metastasis and its dysregulated expression has been observed in many types of cancer.
|
25190487 |
2014 |
Malignant Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
LIM kinase 1 (Limk1) is associated with cell prolife-ration and metastasis and its dysregulated expression has been observed in many types of cancer.
|
25190487 |
2014 |
Primary malignant neoplasm
|
0.080 |
AlteredExpression
|
group |
BEFREE |
LIM kinase 1 (Limk1) is associated with cell prolife-ration and metastasis and its dysregulated expression has been observed in many types of cancer.
|
25190487 |
2014 |
Macrothrombocytopenia
|
0.010 |
Biomarker
|
disease |
BEFREE |
LIM kinase/cofilin dysregulation promotes macrothrombocytopenia in severe von Willebrand disease-type 2B.
|
27734030 |
2016 |
von Willebrand Disease, Type 2B
|
0.010 |
Biomarker
|
disease |
BEFREE |
LIM kinase/cofilin dysregulation promotes macrothrombocytopenia in severe von Willebrand disease-type 2B.
|
27734030 |
2016 |
Tumor Progression
|
0.040 |
Biomarker
|
phenotype |
BEFREE |
PDZ and LIM domain 5 (PDLIM5) is a cytoskeleton-associated protein and has been shown to bind to a variety of proteins through its specific domain, thereby acting to regulate cell migration and tumor progression.
|
29228678 |
2017 |
Osteosarcoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
LIM kinase 1 serves an important role in the multidrug resistance of osteosarcoma cells.
|
29387219 |
2018 |